+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Patterns of failure in patients with medlilloblastoma treated at memorial sloan-kettering cancer center (MSKCC) 19591979



Patterns of failure in patients with medlilloblastoma treated at memorial sloan-kettering cancer center (MSKCC) 19591979



International Journal of Radiation Oncology*biology*physics 6(10): 1443-1444




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 061590976

Download citation: RISBibTeXText

DOI: 10.1016/0360-3016(80)90565-9


Related references

Osteonecrosis of the jaw (ONJ) among intravenous (IV) bisphosphonate- and/or bevacizumab-treated patients (pts) at Memorial Sloan-Kettering Cancer Center (MSKCC). Journal of Clinical Oncology 26(15_Suppl): 9588-9588, 2016

Treatment outcome and incidence for late relapse of germ cell tumor (GCT) patients (pts): The memorial Sloan-Kettering Cancer Center (MSKCC) experience. Journal of Clinical Oncology 23(16_Suppl): 4522-4522, 2016

Tolerance of bevacizumab in an older patient population: The Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Journal of Clinical Oncology 26(15_Suppl): 9569-9569, 2016

Ethmoid Sinus Cancer: Experience and Oncological Outcomes at Memorial Sloan-Kettering Cancer Center (MSKCC). International Journal of Radiation Oncology*biology*physics 88(2): 520-521, 2014

Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center (MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma. Cellular Oncology 39(1): 15-21, 2016

Pancreatic adenocarcinoma (PAC) in a younger patient population: 10-year experience at Memorial Sloan-Kettering Cancer Center (MSKCC). Journal of Clinical Oncology 26(15_Suppl): 4623-4623, 2016

The Memorial Sloan-Kettering Cancer Center (MSKCC) experience with outpatient administration of high-dose methotrexate with leucovorin rescue. Journal of Clinical Oncology 23(16_Suppl): 9003-9003, 2016

Permanent iodine 125 implant for primary unresectable adenocarcinoma of the pancreas the memorial sloan kettering cancer center mskcc experience. International Journal of Radiation Oncology, Biology, Physics 15(Suppl. 1): 117, 1988

Use of prognostic factors in deciding therapy for adult acute lymphoblastic leukemia: new approaches at Memorial Sloan-Kettering Cancer Center (MSKCC). Bone Marrow Transplantation 4(Suppl. 1): 86-89, 1989

Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Pediatric Blood and Cancer 60(4): 694-699, 2013

Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. RadioTherapy and Oncology 87(1): 17-23, 2008

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center. Journal of Clinical Oncology 33(28): 3193-3198, 2015

Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center. Neuro-Oncology 14(10): 1304-1311, 2012

Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancer. Journal of Clinical Oncology 14(3): 796-799, 1996

Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center Experience. Urology 95: 128-131, 2016